Reference,Reference: DOI,Assay,Section,Pre-vaccine Infection,Vaccine,# Shots,Months,Host,Control,Control: NT50 Cmp,Control: NT50 GeoMean,Control: NT50 GSD,Variant,Variant: Pos,Variant: Mutations,# Results,Potency: NT50 Cmp,Potency: NT50 GeoMean,Potency: NT50 GSD,Fold Reduction: Cmp,Fold Reduction: Median
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2B,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,5832.0,1.0,Beta,18,L18F + D80A + D215G + Δ241-244 + K417N + E484K + N501Y + A701V,1,=,1967.0,1.0,=,3.0
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2B,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,1816.0,1.0,Beta,18,L18F + D80A + D215G + Δ241-244 + K417N + E484K + N501Y + A701V,1,=,174.0,1.0,=,10.4
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2B,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,1087.0,1.0,Beta,18,L18F + D80A + D215G + Δ241-244 + K417N + E484K + N501Y + A701V,1,=,107.0,1.0,=,10.2
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2B,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,874.0,1.0,Beta,18,L18F + D80A + D215G + Δ241-244 + K417N + E484K + N501Y + A701V,1,=,154.0,1.0,=,5.7
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2B,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,843.0,1.0,Beta,18,L18F + D80A + D215G + Δ241-244 + K417N + E484K + N501Y + A701V,1,=,107.0,1.0,=,7.9
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2B,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,650.0,1.0,Beta,18,L18F + D80A + D215G + Δ241-244 + K417N + E484K + N501Y + A701V,1,=,75.0,1.0,=,8.7
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2B,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,5658.0,1.0,Beta,18,L18F + D80A + D215G + Δ241-244 + K417N + E484K + N501Y + A701V,1,=,829.0,1.0,=,6.8
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2B,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,4310.0,1.0,Beta,18,L18F + D80A + D215G + Δ241-244 + K417N + E484K + N501Y + A701V,1,=,1764.0,1.0,=,2.4
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2B,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,3383.0,1.0,Beta,18,L18F + D80A + D215G + Δ241-244 + K417N + E484K + N501Y + A701V,1,=,93.0,1.0,=,36.4
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2B,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,2292.0,1.0,Beta,18,L18F + D80A + D215G + Δ241-244 + K417N + E484K + N501Y + A701V,1,=,342.0,1.0,=,6.7
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2B,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,2247.0,1.0,Beta,18,L18F + D80A + D215G + Δ241-244 + K417N + E484K + N501Y + A701V,1,=,607.0,1.0,=,3.7
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2B,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,2071.0,1.0,Beta,18,L18F + D80A + D215G + Δ241-244 + K417N + E484K + N501Y + A701V,1,=,270.0,1.0,=,7.7
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2B,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,1973.0,1.0,Beta,18,L18F + D80A + D215G + Δ241-244 + K417N + E484K + N501Y + A701V,1,=,501.0,1.0,=,3.9
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2B,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,1865.0,1.0,Beta,18,L18F + D80A + D215G + Δ241-244 + K417N + E484K + N501Y + A701V,1,=,344.0,1.0,=,5.4